Adagene Inc.
(NASDAQ:ADAG)
$1.75
0.26 (17.45%)
At Close: 4:00 PM
Adagene Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
Adagene Stock Price Today
Adagene Inc. (ADAG) stock rallied over 19.05% intraday to trade at $1.75 a share on NASDAQ. The stock opened with a loss of -7.91% at $1.35 and touched an intraday high of $1.36, rising 19.05% against the last close of $1.47. The Adagene Inc. in stock market went to a low of $1.34 during the session.
Adagene Stock Snapshot
$1.47
Prev. Close
75.69 Million
Market Cap
$1.34
Day Low
$1.35
Open
N/A
Number of Shares
$1.36
Day High
N/A
P/E ratio
-0.84
EPS (TTM)
2.35
Cash Flow per Share
N/A
Free Float in %
1.89
Book Value
55682.00
Volume
Adagene Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
BetaN/A
Sales or Revenue$22.67 Million
5Y Sales Change330.18%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid tumors and non-Hodgkin's lymphoma; ADG126, a fully-human anti-CTLA-4 mAb that is in Phase 1 clinical trial for the treatment advanced/metastatic solid tumors; and ADG116, a human ligand-blocking anti-CTLA-4 mAb, which is in Phase I clinical trial for the treatment of advanced metastatic solid tumors. It also offers ADG104, an anti-PD-L1 mAb that is in Phase 2 clinical development; ADG125, a novel anti-CSF-1R mAb, which is in Phase I clinical trial; ADG206, a masked, Fc engineered anti-CD137 agonistic POWERbody, which is in preclinical; ADG153, a masked anti-CD47 IgG1 SAFEbody, which is in preclinical stage for the treatment hematologic and solid tumors; ADG138, novel HER2xCD3 POWERbody, which is in preclinical for the treatment HER2-expressing solid tumors; and ADG152, a CD20xCD3 POWERbody, which is in preclinical stage for the treatment off-tumor toxicities. The company was incorporated in 2011 and is headquartered in Suzhou, China.
Peers
Frequently Asked Questions
What is the current Adagene Inc. (ADAG) stock price?
Adagene Inc. (NASDAQ: ADAG) stock price is $1.75 in the last trading session. During the trading session, ADAG stock reached the peak price of $1.36 while $1.34 was the lowest point it dropped to. The percentage change in ADAG stock occurred in the recent session was 19.05% while the dollar amount for the price change in ADAG stock was $0.28.
ADAG's industry and sector of operation?
The NASDAQ listed ADAG is part of Biotechnology industry that operates in the broader Healthcare sector. Adagene Inc. , a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers.
Who are the executives of ADAG?
Dr. Peter P. Luo Ph.D.
Co-Founder, Chief Executive Officer & Chairman
Ms. Xiaohong She
Senior Vice President & Head of Clinical Operations
Ms. Ami Celeste Knoefler
Vice President of Investor Relations & Corporation Communications
Mr. Man Kin Tam M.B.A.
Chief Financial Officer & Director
How ADAG did perform over past 52-week?
ADAG's closing price is 0.44% higher than its 52-week low of $0.9 where as its distance from 52-week high of $2.1 is -0.65%.
How many employees does ADAG have?
Number of ADAG employees currently stands at N/A. ADAG operates from Building C14, Suzhou, 215123, CN.
Link for ADAG official website?
Official Website of ADAG is: https://www.adagene.com
How do I contact ADAG?
ADAG could be contacted at phone #86 512 8777 3632 and can also be accessed through its website. ADAG operates from Building C14, Suzhou, 215123, CN.
How many shares of ADAG are traded daily?
ADAG stock volume for the day was 55682.00 shares. The average number of ADAG shares traded daily for last 3 months was 15.64 Thousands.
What is the market cap of ADAG currently?
The market value of ADAG currently stands at $75.69 Million with its latest stock price at $1.75 and N/A of its shares outstanding.